Connective tissue disease in patients presenting with Raynaud's phenomenon alone.

بواسطة Kallenberg, C G
منشور في 1991

A 10% ready-to-use intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency

بواسطة Kallenberg, C G M
منشور في 2007

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: where to go?

بواسطة Kallenberg, C G M
منشور في 2011

Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

بواسطة Roozendaal, C, Kallenberg, C G M
منشور في 1999

Treatment of severe thrombocytopenia in systemic lupus erythematosus with intravenous gammaglobulin.

بواسطة ter Borg, E J, Kallenberg, C G
منشور في 1992

The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance...

بواسطة Roenhorst, H W, Kallenberg, C G, The, T H
منشور في 1988

Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppression.

بواسطة Kallenberg, C G, de Gast, G C, The, T H
منشور في 1980

Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA.

بواسطة Mulder, A H, Stegeman, C A, Kallenberg, C G
منشور في 1995

Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease?

بواسطة Houtman, P M, Kallenberg, C G, Wouda, A A, The, T H
منشور في 1985

Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.

بواسطة Kallenberg, C G, Pastoor, G W, Wouda, A A, The, T H
منشور في 1982

Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?

بواسطة Spronk, P E, ter Borg, E J, Kallenberg, C G
منشور في 1992

Transient arthritis with positive tests for rheumatoid factor as presenting sign of shunt nephritis.

بواسطة ter Borg, E J, Van Rijswijk, M H, Kallenberg, C G
منشور في 1991

Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)

بواسطة Bijl, M, Horst, G, Limburg, P C, Kallenberg, C G M
منشور في 2001

Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis

بواسطة Hettema, M E, Zhang, D, Bootsma, H, Kallenberg, C G M
منشور في 2007

Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.

بواسطة ter Borg, E J, Horst, G, Limburg, P C, Kallenberg, C G
منشور في 1990

Serum markers of T cell activation in relapses of Wegener's granulomatosis.

بواسطة Stegeman, C A, Tervaert, J W, Huitema, M G, Kallenberg, C G
منشور في 1993

B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activati...

بواسطة Spronk, P E, vd Gun, B T, Limburg, P C, Kallenberg, C G
منشور في 1993

B cell epitope specificity in ANCA-associated vasculitis: does it matter?

بواسطة VAN DER GELD, Y M, STEGEMAN, C A, KALLENBERG, C G M
منشور في 2004

Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies

بواسطة Van Der Geld, Y M, Limburg, P C, Kallenberg, C G M
منشور في 1999

Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as d...

بواسطة Kallenberg, C G, Wouda, A A, Hoet, M H, van Venrooij, W J
منشور في 1988